- Home
- LPG vs MDXG Comparison
LPG vs MDXG Comparison
Compare LPG & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPG
- MDXG
- Stock Information
- Founded
- LPG 2013
- MDXG 2006
- Country
- LPG United States
- MDXG United States
- Employees
- LPG N/A
- MDXG N/A
- Industry
- LPG Marine Transportation
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- LPG Consumer Discretionary
- MDXG Health Care
- Exchange
- LPG Nasdaq
- MDXG Nasdaq
- Market Cap
- LPG 1.2B
- MDXG 1.0B
- IPO Year
- LPG 2014
- MDXG N/A
- Fundamental
- Price
- LPG $24.73
- MDXG $6.88
- Analyst Decision
- LPG Strong Buy
- MDXG Buy
- Analyst Count
- LPG 1
- MDXG 1
- Target Price
- LPG $35.00
- MDXG $12.00
- AVG Volume (30 Days)
- LPG 522.8K
- MDXG 1.2M
- Earning Date
- LPG 11-06-2025
- MDXG 10-29-2025
- Dividend Yield
- LPG 13.02%
- MDXG N/A
- EPS Growth
- LPG N/A
- MDXG N/A
- EPS
- LPG 2.23
- MDXG 0.27
- Revenue
- LPG $359,008,462.00
- MDXG $393,442,000.00
- Revenue This Year
- LPG $17.26
- MDXG $19.01
- Revenue Next Year
- LPG N/A
- MDXG $2.36
- P/E Ratio
- LPG $11.04
- MDXG $25.47
- Revenue Growth
- LPG N/A
- MDXG 14.77
- 52 Week Low
- LPG $16.66
- MDXG $5.79
- 52 Week High
- LPG $32.79
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- LPG 34.06
- MDXG 46.10
- Support Level
- LPG $24.06
- MDXG $6.45
- Resistance Level
- LPG $29.73
- MDXG $6.96
- Average True Range (ATR)
- LPG 0.82
- MDXG 0.27
- MACD
- LPG -0.19
- MDXG -0.06
- Stochastic Oscillator
- LPG 17.87
- MDXG 38.06
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.